Press Release TOKYO 6th April
OUI Inc., announced today that our medical device Smart Eye Camera (SEC), a smartphone attachment which function as a conventional slit-lamp microscope and is able to record the ophthalmological images and videos, has got listed in the Valued Supplier List of the International Agency of the Prevention of Blindness (IAPB), for the first time as a medical device from Japanese corporate.
The International Agency for the Prevention of Blindness (IAPB) is the peak body for the global eye care sector. IAPB has over 150 members worldwide drawn from NGOs and civil society, corporate organisations, professional bodies and research and eye care institutions.
IAPB was founded in 1975 to lead international efforts in blindness prevention activities. They work towards a world where no one is needlessly visually impaired, in which everyone has access to the best possible standard of eye health, and eye care is a core part of Universal Health Coverage.
IAPB works alongside the World Health Organization (WHO) in prevention of blindness, and promoting the WHO newly published World Report on Vision, which is being launched in a number of countries during 2020.
The IAPB Standard List / Valued Supplier List, which SEC is listed on, is a platform managed by IAPB to source and compare eye health products and technologies for eye care professionals to identify and purchase high-quality eye care equipment at the right price. The List provides only products carefully evaluated by IAPB.
It is for the first time as a medical device from Japanese Corporate to be in the Valued Supplier List by IAPB.
Blindness continues to remain a major problem worldwide. WHO announced that at least a billion people have a visual impairment that can be prevented or has yet to be addressed. Over half of these blindness incidents were caused by cataracts.
We find a large possibility for SEC to overcome this issue, enabling eye diagnosis anywhere with its portability and easiness to handle.
Starting from this collaboration, we will seek further possibilities for collaboration/partnership with IAPB, thereby we aim to achieve our vision; to overcome 50% of the world blindness by the year 2025 with SEC.
SEC is a certified Slit-Lamp medical device in Japan, a smartphone attachment which allows Ophthalmic examination only by the smartphone. It was invented by our founders, 3 ophthalmologists from Keio University School of Medicine.
It is the first Japanese medical device for eye diagnosis which utilizes the camera and the light source of iPhone.
SEC is proven to have equal performance to the conventional professional slit-lamp microscope used in Ophthalmology clinics through animal experiments*. We are now under preparation for the evidence study with human experiments too.
We undertake various clinical researches both in domestic and international fields, and we are always open to our new partners for such research studies.
*Shimizu E, Ogawa Y, Yazu H, Aketa N, et al, Plos One 2019.
It is said that the population of the blind reaches 36 million, and the number will get tripled after 30 years. OUI Inc. has started pilot projects of SEC not only in Japan but also in the countries such as Vietnam, Mongolia, Zambia, Malawi with a partnership with local medical institutions. We aim to overcome 50% of the world blindness by the year 2025 with SEC.
※SEC has internationally patented, an approved medical device in Japan**, with some of the toughest regulations worldwide.
About OUI Inc.
OUI Inc. is a company founded by 3 Japanese ophthalmologists from Keio University School of Medicine, with the goal to overcome world blindness by combining their knowledge in the field with new ideas to push the development of healthcare.
Name : OUI Inc.
URL : https://ouiinc.jp/en/
Address : 3F, 1-36-2, Shinjuku, Shinjuku-ku, 160-0022, Tokyo, Japan
CEO : Eisuke SHIMIZU
Director : Hiroyuki YAZU
Founded : 15th July, 2016
VP of Global Business, OUI Inc.
mail: [email protected]
Join a powerful, unprecedented alliance for better eye health for all.
Bringing you the latest information on eye care products, suppliers and prices.